Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4330090 | Brain Research | 2008 | 9 Pages |
Abstract
Secretion and progressive cerebral accumulation of β-amyloid peptides (Aβ) derived by endoproteolytic (“amyloidogenic”) processing of β-amyloid precursor protein (APP) represent collectively an early and necessary event in the pathogenesis of Alzheimer's disease. We previously demonstrated that secretion of the neurotoxic species Aβ42 increases during staurosporine-induced apoptosis in undifferentiated PC12 cells, in an endocytosis-dependent manner. In the present study, we tested whether phosphorylation of the APP cytoplasmic-tail is contributory to this apoptosis-related increased Aβ-secretory response. We demonstrate that cytoplasmic-tail phosphorylation specifically at amino-acid residue T668 (APP-695 numbering) increases during staurosporine-induced apoptosis, in parallel with activation of the mitogen-activated, proline-directed serine/threonine protein kinase ERK1. We demonstrate additionally that specific ERK inhibition during staurosporine induction, with serum-free conditions, results in down-regulation of APP phosphorylation at T668, together with attenuation of the increased Aβ-secretory response. These results are consistent with APP cytoplasmic-tail phosphorylation at T668 during apoptosis as contributory to increased Aβ42 secretion originating from the endocytotic pathway, likely with cell-line restriction.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Chhinder P. Sodhi, Ruth G. Perez, Numa R. Gottardi-Littell,